# Clinical Efficacy of Two Erythropoietin Drug in Participants With Secondary Anemia to Chronic Kidney Disease.

> **NCT01695759** · PHASE3 · TERMINATED · sponsor: **Azidus Brasil** · enrollment: 92 (actual)

## Conditions studied

- Chronic Kidney Disease
- Anemia

## Interventions

- **DRUG:** Epoetin alpha
- **DRUG:** Eprex

## Key facts

- **NCT ID:** NCT01695759
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-12
- **Primary completion:** 2014-12
- **Final completion:** 2018-01
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2018-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01695759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01695759, "Clinical Efficacy of Two Erythropoietin Drug in Participants With Secondary Anemia to Chronic Kidney Disease.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01695759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*